KRAS Inhibition May Improve Efficacy of Immune Checkpoint Blockade in Lung Cancer - AJMC.com Managed Markets Network

The research may eventually help clinicians optimize therapy with immune checkpoint inhibitors.

New research suggests that some patients with lung cancer might benefit from combining a KRAS inhibitor with immune checkpoint inhibition, according to a new report. The study, published in Science … [+3524 chars]

full article...